Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000239930 | SCV000299153 | pathogenic | Lynch syndrome | 2016-03-14 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 1-5 of the PMS2 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 5 of the PMS2 gene. While this variant has not been reported in individuals affected with a PMS2-related disease, deletions of exon 1 and exons 1-6 of PMS2 have been reported in patients affected with colorectal cancer (PMID: 18809606, 20205264). This variant is expected to abrogate the initiation of protein translation and potentially disrupt transcription of the mRNA of PMS2. For these reasons, this variant has been classified as Pathogenic. |